Skip to main content

Table 2 Adverse events of Cardiorenal type 1 patients according to allocation groups during the study period

From: The Effect in Renal Function and Vascular Decongestion in Type 1 Cardiorenal Syndrome Treated with Two Strategies of Diuretics, a Pilot Randomized Trial

  All patients,
n = 80
Stepped Furosemide,
n = 40
Combined Diuretics
n = 40
p value
Any adverse event (%) 68 (85) 35 (7.5) 33 (82.5) 0.53
Metabolic alkalosis (%) 24 (30) 12 (30) 12 (30) 0.60
Hypokalemia (%) 15 (18.8) 8 (20) 7 (17.5) 0.78
Hyponatremia (%) 36 (45) 18 (45) 18 (45) 1.0
Hypotension (%) 5 (6.2) 4 (10) 1 (2.5) 0.35